Oic Pamora denied as not medically necessary by Humana?

Humana's specific coverage criteria for oic pamora are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies PAMORAs for OIC on Medical-Necessity Grounds

Humana's medical-necessity denials for peripherally acting mu-opioid receptor antagonists (PAMORAs) in opioid-induced constipation (OIC) typically occur because the submitted documentation did not fully establish: (1) a confirmed OIC diagnosis distinct from general constipation; (2) an adequate trial of conventional bowel-regimen therapy with documented inadequate response; and (3) that the patient is on a stable chronic opioid regimen for a legitimate pain indication. Humana's internal coverage criteria mirror the FDA-approved indication requirements and may add additional plan-specific steps. When chart documentation is incomplete, an automated or clinical reviewer denies on medical-necessity grounds.

## Why This Denial Is Appealable

Medical-necessity denials are among the most commonly appealed and overturned when complete documentation is submitted:

• Internal appeal (ERISA §503 / ACA §2719): File a formal written appeal with the documentation categories below. Plans must provide a full-and-fair review.
• External review (ACA §2719): After internal exhaustion, or at 4 months from the denial date, you may request Independent Review Organization review. The IRO's decision is binding on the plan.
• Expedited review: Available if standard timelines would seriously jeopardize your health — for example, if OIC is causing clinically significant harm or jeopardizing your ability to continue medically necessary opioid therapy.

## Documentation to Gather

1. OIC diagnosis confirmation: Chart notes documenting that constipation began or worsened in temporal correlation with opioid initiation or dose increase, and that your physician has diagnosed OIC specifically. 2. Chronic opioid therapy documentation: Records confirming the pain diagnosis, the opioid prescribed, the duration of therapy, and that the opioid regimen is stable and medically necessary. 3. Conventional laxative trial history: A dated list of all bowel-regimen agents tried (fiber, osmotic agents, stimulants, stool softeners), with duration of each trial, doses per your physician's notes, and the specific reason each was inadequate. 4. Symptom impact documentation: Chart notes or a physician-completed functional assessment showing how OIC is affecting your daily function, nutrition, or ability to tolerate opioid therapy. 5. Prescriber medical-necessity letter: A letter from your treating physician explicitly addressing each of Humana's published coverage criteria for the PAMORA class, with specific chart references.

## Criteria-Mapping Structure

Download Humana's coverage policy for the PAMORA drug class from humana.com (search "Coverage Policies" or "Drug Coverage Criteria"). Print each coverage criterion. Create a two-column response: left column lists each criterion verbatim; right column provides the specific chart fact, date, and document satisfying it. Submit this table as the centerpiece of your appeal letter.

## Next Step

Ask your prescriber's office to request a peer-to-peer review with Humana's reviewing physician before or alongside the written appeal. Peer-to-peer conversations allow your physician to directly address the clinical reasoning behind the prescription and frequently result in faster reversal than written appeals alone.